Free Trial
NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$1.81 -0.07 (-3.72%)
As of 06/27/2025 04:00 PM Eastern

About Gelteq Stock (NASDAQ:GELS)

Key Stats

Today's Range
$1.75
$1.94
50-Day Range
$0.90
$2.95
52-Week Range
$0.77
$5.50
Volume
97,815 shs
Average Volume
4.03 million shs
Market Capitalization
$17.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

GELS Stock News Headlines

Gelteq Aktie | GELS Kurs | Realtime - Investing.com
Gelteq Ltd.
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
Gelteq Limited Ordinary Shares (GELS)
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $2.32 at the start of the year. Since then, GELS stock has decreased by 22.0% and is now trading at $1.81.
View the best growth stocks for 2025 here
.

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100 thousand
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$17.09 million
Optionable
N/A
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners